Literature DB >> 23536093

Purkinje cell ataxin-1 modulates climbing fiber synaptic input in developing and adult mouse cerebellum.

Blake A Ebner1, Melissa A Ingram, Justin A Barnes, Lisa A Duvick, Jill L Frisch, H Brent Clark, Huda Y Zoghbi, Timothy J Ebner, Harry T Orr.   

Abstract

Previous studies indicate that while transgenic mice with ATXN1[30Q]-D776-induced disease share pathological features caused by ATXN1[82Q] having an expanded polyglutamine tract, they fail to manifest the age-related progressive neurodegeneration seen in spinocerebellar ataxia type 1. The shared features include morphological alterations in climbing fiber (CF) innervation of Purkinje cells (PCs). To further investigate the ability of ataxin-1 (ATXN1) to impact CF/PC innervation, this study used morphological and functional approaches to examine CF/PC innervation during postnatal development in ATXN1[30Q]-D776 and ATXN1[82Q] cerebella. Notably, ATXN1[30Q]-D776 induced morphological alterations consistent with the development of the innervation of PCs by CFs being compromised, including a reduction of CF translocation along the PC dendritic tree, and decreased pruning of CF terminals from the PC soma. As previously shown for ATXN1[82Q], ATXN1[30Q]-D776 must enter the nucleus of PCs to induce these alterations. Experiments using conditional ATXN1[30Q]-D776 mice demonstrate that both the levels and specific timing of mutant ATXN1 expression are critical for alteration of the CF-PC synapse. Together these observations suggest that ATXN1, expressed exclusively in PCs, alters expression of a gene(s) in the postsynaptic PC that are critical for its innervation by CFs. To investigate whether ATXN1[30Q]-D776 curbs the progressive disease in ATXN1[82Q]-S776 mice, we crossed ATXN1[30Q]-D776 and ATXN1[82Q]-S776 mice and found that double transgenic mice developed progressive PC atrophy. Thus, the results also show that to develop progressive cerebellar degeneration requires expressing ATXN1 with an expanded polyglutamine tract.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23536093      PMCID: PMC3633086          DOI: 10.1523/JNEUROSCI.6311-11.2013

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  49 in total

1.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

Review 2.  Activity-dependent plasticity of developing climbing fiber-Purkinje cell synapses.

Authors:  L W J Bosman; A Konnerth
Journal:  Neuroscience       Date:  2009-01-23       Impact factor: 3.590

Review 3.  The cells and molecules that make a cerebellum.

Authors:  D Goldowitz; K Hamre
Journal:  Trends Neurosci       Date:  1998-09       Impact factor: 13.837

4.  The expression of vesicular glutamate transporters defines two classes of excitatory synapse.

Authors:  R T Fremeau; M D Troyer; I Pahner; G O Nygaard; C H Tran; R J Reimer; E E Bellocchio; D Fortin; J Storm-Mathisen; R H Edwards
Journal:  Neuron       Date:  2001-08-02       Impact factor: 17.173

5.  Abnormalities in the climbing fiber-Purkinje cell circuitry contribute to neuronal dysfunction in ATXN1[82Q] mice.

Authors:  Justin A Barnes; Blake A Ebner; Lisa A Duvick; Wangcai Gao; Gang Chen; Harry T Orr; Timothy J Ebner
Journal:  J Neurosci       Date:  2011-09-07       Impact factor: 6.167

6.  SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat.

Authors:  E N Burright; H B Clark; A Servadio; T Matilla; R M Feddersen; W S Yunis; L A Duvick; H Y Zoghbi; H T Orr
Journal:  Cell       Date:  1995-09-22       Impact factor: 41.582

7.  TrkB is necessary for pruning at the climbing fibre-Purkinje cell synapse in the developing murine cerebellum.

Authors:  Erin M Johnson; Ethan T Craig; Hermes H Yeh
Journal:  J Physiol       Date:  2007-04-26       Impact factor: 5.182

8.  Mice lacking ataxin-1 display learning deficits and decreased hippocampal paired-pulse facilitation.

Authors:  A Matilla; E D Roberson; S Banfi; J Morales; D L Armstrong; E N Burright; H T Orr; J D Sweatt; H Y Zoghbi; M M Matzuk
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

9.  Diminished climbing fiber innervation of Purkinje cells in the cerebellum of myosin Va mutant mice and rats.

Authors:  Yoshiko Takagishi; Kouichi Hashimoto; Tetsuro Kayahara; Masahiko Watanabe; Hiroyuki Otsuka; Akira Mizoguchi; Masanobu Kano; Yoshiharu Murata
Journal:  Dev Neurobiol       Date:  2007-06       Impact factor: 3.964

10.  A gene expression atlas of the central nervous system based on bacterial artificial chromosomes.

Authors:  Shiaoching Gong; Chen Zheng; Martin L Doughty; Kasia Losos; Nicholas Didkovsky; Uta B Schambra; Norma J Nowak; Alexandra Joyner; Gabrielle Leblanc; Mary E Hatten; Nathaniel Heintz
Journal:  Nature       Date:  2003-10-30       Impact factor: 49.962

View more
  24 in total

Review 1.  The role for alterations in neuronal activity in the pathogenesis of polyglutamine repeat disorders.

Authors:  Ravi Chopra; Vikram G Shakkottai
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

2.  Decreased expression of glutamate transporter GLAST in Bergmann glia is associated with the loss of Purkinje neurons in the spinocerebellar ataxia type 1.

Authors:  Marija Cvetanovic
Journal:  Cerebellum       Date:  2015-02       Impact factor: 3.847

3.  Abnormal climbing fibre-Purkinje cell synaptic connections in the essential tremor cerebellum.

Authors:  Chi-Ying Lin; Elan D Louis; Phyllis L Faust; Arnulf H Koeppen; Jean-Paul G Vonsattel; Sheng-Han Kuo
Journal:  Brain       Date:  2014-10-01       Impact factor: 13.501

4.  Climbing fiber-Purkinje cell synaptic pathology in tremor and cerebellar degenerative diseases.

Authors:  Sheng-Han Kuo; Chi-Ying Lin; Jie Wang; Peter A Sims; Ming-Kai Pan; Jyun-You Liou; Danielle Lee; William J Tate; Geoffrey C Kelly; Elan D Louis; Phyllis L Faust
Journal:  Acta Neuropathol       Date:  2016-10-04       Impact factor: 17.088

5.  Mutant ataxin1 disrupts cerebellar development in spinocerebellar ataxia type 1.

Authors:  Chandrakanth Reddy Edamakanti; Jeehaeh Do; Alessandro Didonna; Marco Martina; Puneet Opal
Journal:  J Clin Invest       Date:  2018-04-23       Impact factor: 14.808

6.  Transient cerebellar alterations during development prior to obvious motor phenotype in a mouse model of spinocerebellar ataxia type 6.

Authors:  Sriram Jayabal; Lovisa Ljungberg; Alanna J Watt
Journal:  J Physiol       Date:  2016-10-02       Impact factor: 5.182

7.  Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1.

Authors:  M Cvetanovic; M Ingram; H Orr; P Opal
Journal:  Neuroscience       Date:  2015-01-14       Impact factor: 3.590

8.  Reduction of protein kinase A-mediated phosphorylation of ATXN1-S776 in Purkinje cells delays onset of Ataxia in a SCA1 mouse model.

Authors:  Judit M Pérez Ortiz; Nissa Mollema; Nicholas Toker; Carolyn J Adamski; Brennon O'Callaghan; Lisa Duvick; Jillian Friedrich; Michael A Walters; Jessica Strasser; Jon E Hawkinson; Huda Y Zoghbi; Christine Henzler; Harry T Orr; Sarita Lagalwar
Journal:  Neurobiol Dis       Date:  2018-05-11       Impact factor: 5.996

9.  A Chemical Biology Approach to Model Pontocerebellar Hypoplasia Type 1B (PCH1B).

Authors:  Liberty François-Moutal; Shahriyar Jahanbakhsh; Andrew D L Nelson; Debashish Ray; David D Scott; Matthew R Hennefarth; Aubin Moutal; Samantha Perez-Miller; Andrew J Ambrose; Ahmed Al-Shamari; Philippe Coursodon; Bessie Meechoovet; Rebecca Reiman; Eric Lyons; Mark Beilstein; Eli Chapman; Quaid D Morris; Kendall Van Keuren-Jensen; Timothy R Hughes; Rajesh Khanna; Carla Koehler; Joanna Jen; Vijay Gokhale; May Khanna
Journal:  ACS Chem Biol       Date:  2018-09-06       Impact factor: 5.100

10.  Astroglia contribute to the pathogenesis of spinocerebellar ataxia Type 1 (SCA1) in a biphasic, stage-of-disease specific manner.

Authors:  Joo Hyun Kim; Abigail Lukowicz; Wenhui Qu; Andrea Johnson; Marija Cvetanovic
Journal:  Glia       Date:  2018-07-25       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.